Whoa.... stopped to take a peak and WOW!
Looks like we're "knee-deep in the AYCE* club!"
They can cast aspersions
But Leronlimab's MOA (mechanism of action) and lack of "nasty " (so far) side-effects
Makes it (IMO) >>> "Golden"
And ...
First - BP KNOWS >> of Leronlimab's existence/potential mega-billion money maker [in their hands]/BUT potential SUBSTANTIAL threat to their drug lines if allowed to exist.
And a round of applause for the AYCE club spending their timmmmmmmmmmmmme here!
(Muffled applause dwindles out)
(and guess who supports the "AYCE-club presence" DUH!)
But sooner or later
There's "gonna be a 'leak in the dike" and the brotherhood/sisterhood of Big Pharma is going to 'fracture viciously as different entities spring to secure the profitable rights/licenses to Leronlimab's numerous applications both as a primary agent and as an adjuvant ( greatly multiplying potential applications).
Like tossing bloody meat into the piranha pool, LOL.
And...how far away is the moment?
the Juicy,pink meat
splashes in?
6mo? a year? 18mos? (the brotherhood of pharma is only annual report deeeeeeep.)
Some repugnant lawsuits and poor earnings could initiate a need for
Solidifying future income - the "new-big-hitter" on the drug-lineup.
>>...and then the fun begins.
Except
Very unfortunately,
the "AYCE club" will be
"pounding the pavement."
(Funny thought - many of them might be significant holders of shares - they're here all day, get to see some convincing info, and certainly track issue better than I can...
Hmmmm, maybe they're walking away with big smiles.
IRONY
IMO
*AYCE = acronym for All You Can Eat.
